These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1966885)

  • 21. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post-transfusion cytomegalovirus infections. The position in 1987].
    Andreu G; Bierling P; Brossard Y; Foucault C; Girard M; Gluckman E; Huart JJ; Janot C; Marinière AM; Mazeron MC
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):331-6. PubMed ID: 2832928
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of acute pulmonary edema due to anti-human leukocyte antigen antibody reaction].
    Satoh Y; Tachi H; Takayama S; Miyahara Y; Aoyagi Y; Inada M; Miura H; Korenaga M; Kanayama M; Oohira M
    Nihon Naika Gakkai Zasshi; 1987 Sep; 76(9):1424-8. PubMed ID: 3430034
    [No Abstract]   [Full Text] [Related]  

  • 25. [Transfusion-related lung injury edema].
    Fruchart MF; Klaren J; Belhocine R; Ben Hadj Amor H
    Rev Med Interne; 1999 Sep; 20(9):781-4. PubMed ID: 10522300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leukocyte depletion].
    Bégué S
    Transfus Clin Biol; 1998 Dec; 5(6):411-4. PubMed ID: 9894332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leucocyte depletion of the blood supply - how will patients benefit?
    Williamson LM
    Br J Haematol; 2000 Aug; 110(2):256-72. PubMed ID: 10971381
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukocyte-poor blood components: a purer and safer transfusion product for recipients?
    Rebulla P; Bertolini F; Parravicini A; Sirchia G
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):19-23. PubMed ID: 2134637
    [No Abstract]   [Full Text] [Related]  

  • 29. Febrile reactions to platelet transfusions.
    Mintz PD
    Am J Clin Pathol; 1991 May; 95(5):609-12. PubMed ID: 2024621
    [No Abstract]   [Full Text] [Related]  

  • 30. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units.
    Hillyer CD; Emmens RK; Zago-Novaretti M; Berkman EM
    Transfusion; 1994 Oct; 34(10):929-34. PubMed ID: 7940668
    [No Abstract]   [Full Text] [Related]  

  • 31. Limited efficacy of universal leucodepletion in reducing the incidence of febrile nonhaemolytic reactions in red cell transfusions.
    Ibojie J; Greiss MA; Urbaniak SJ
    Transfus Med; 2002 Jun; 12(3):181-5. PubMed ID: 12071874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
    Gilbert GL; Hayes K; Hudson IL; James J
    Lancet; 1989 Jun; 1(8649):1228-31. PubMed ID: 2566781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of human cytomegalovirus from the circulating leucocytes of a leukaemic patient.
    Jack I; Todd H; Turner EK
    Med J Aust; 1968 Feb; 1(6):210-3. PubMed ID: 4295969
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytomegalovirus infections associated with leukocyte transfusions.
    Winston DJ; Ho WG; Howell CL; Miller MJ; Mickey R; Martin WJ; Lin CH; Gale RP
    Ann Intern Med; 1980 Nov; 93(5):671-5. PubMed ID: 6259981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.
    Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ
    Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of transfusion-associated cytomegalovirus infection: defining the method of preparation for leukocyte-reduced blood products.
    Dumont LJ; Schuyler R
    Blood; 1996 Aug; 88(4):1515. PubMed ID: 8695874
    [No Abstract]   [Full Text] [Related]  

  • 37. A very simple and nonexpensive technique to prevent febrile nonhemolytic transfusion reactions in HLA-immunized patients.
    Matthieu F
    Vox Sang; 1995; 68(3):201-2. PubMed ID: 7625081
    [No Abstract]   [Full Text] [Related]  

  • 38. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.
    Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG
    Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Post-transfusional cytomegalovirus infections: incidence and methods of prevention. CMV group of SNTS].
    Andreu G; Marinière AM; Fretz C; Emile JF; Bierling P; Brossard Y; Girard M; Gluckman E; Huart JJ; Janot C
    Rev Fr Transfus Hemobiol; 1991 May; 34(3):213-32. PubMed ID: 1648357
    [No Abstract]   [Full Text] [Related]  

  • 40. An overview of laboratory and clinical aspects of leucocyte-depleted blood components.
    Seghatchian MJ
    Transfus Sci; 1994 Mar; 15(1):49-56. PubMed ID: 10147198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.